Limits And Clinical Applications

In molecular diagnosis there are two types of variant characterization: one for diseases with a major etiologic mutation, as in medium chain Acyl CoA dehydrogenase deficiency where almost 90% of affected pediatric patients have the same mutation (985A>G). Thus it is a simple matter to design a high-throughput test by either forward dot blot or PCR-RFLP. This, however, is not the case for the second type, CF or p-thalassemia. Hundreds of mutations are known that cause p-thalassemia or hemoglobinopathies, and nearly all are recessive, some causing milder and some more extreme phenotypes. And, even today, after a massive screening effort in the Mediterranean and Italy, where p-thalassemia is endemic, most patients are born into families with no history of the disease. Another example is CF in which one major mutation accounts for 70% of observed carriers and is present in homozygous form in less than 50% of affected individuals. Thus the clinical sensitivity, which is ethnicity specific, is much lower than most diagnostic tests found in a pathology laboratory. Like p-thalassemia, the vast majority of individuals who have CF are born into families with no history of the disease. Each of these diseases has a relatively wide mutation spectrum; that is, many different alleles are present that in combination can give rise to the disease. As a consequence, there is great motivation for carrier screening for each of these diseases, to provide early warning to at-risk families and to ascertain genetic carrier status far back in families presenting for screening. Chehab and his collaborators designed a series of very successful reverse dot blots aimed at these applications.1-19-21-1 As the CF LAp offered by Roche Diagnostics and Innogenetics' Line Probe Assay (LiPA) have received the broad endorsement of U.S. molecular diagnostics laboratories, the RLB has come of age. In addition to these commercial offerings, there remains a large market of home-brew testing via reverse allele-specific oligonucleotides, for a variety of hereditary illness and infectious-disease typing. With the recent publication and evaluation of a 58-allele line probe assay by a Johns Hopkins and Roche Molecular Systems collaborative group,[11] the RLB has proved its analytical utility in a variety of diagnostic situations. Limitations, such as the individuals who are compound heterozygote at closely spaced loci, occasionally fail to signal the presence of one or the other allele. This is because of interference. It is a characteristic of all sequence-specific assays that nucleotide variants within the probed region (usually ~ 17 nucleotides) affect test accuracy. One example of this kind of interaction is detection of a S549N/R553X heterozygote in Wang et al.;[11] this failed to hybridize with the G551D wild-type probe which is encompassed by the probe for R553X. Another example is a AF508 mutation/I506V polymorphism heterozygote which failed to hybridize against the normal sequence in the region. These confounding results should notify the alert clinician of a test uncertainty that bears further investigation. This type of observation is one of the motives for the American College of Medical Genetics (ACMG) guideline of a two-tiered testing strategy for population-based CF screening.[22]

(HBV and HCV). Several diagnostics manufacturers have participated in the development of RLBs. There will undoubtedly be many improvements in automation and detection of DNA sequences using this technology in the short-term future.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment